Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

NCT00934921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ondansetron
DRUG: Zofran®

Sponsor

Teva Pharmaceuticals USA